InsidersTradesSigma
Track the 润达医疗 share price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 润达医疗 has recorded 11 reports. Market capitalisation: €6.4bn. The latest transaction was disclosed on 17 June 2026 (Sale). Among the most active insiders: 陈政. The full history is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€11m
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,675 of 29,063 companies
32.2
score / 100
Value44
Quality21
FCF yld6.3%
Earn yld-9.0%
EV/EBITDA·
ROE-9.5%
Gross mgn21%
Net mgn-7.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 June 2026
Declarations11 total
1,267,700 sharesA股XSHGSSE:173000006285450980
11 of 11 declarations
关于 润达医疗
润达医疗是一家医疗保健和制药领域的公司，在上海证券交易所上市。它专注于医疗设备和创新健康解决方案的开发和制造。